课题基金 / 基金详情

TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'S DISEASE

TRIAL OF ETHYL-EPA IN SUBJECTS WITH MILD TO MODERATE HUNTINGTON'S DISEASE
乙基-EPA 在轻度至中度亨廷顿病受试者中的试验
批准号:
7606583
负责人:
JODY COREY-BLOOM
金额:
$0.04万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

JODY COREY-BLOOM的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 与安慰剂相比,在6个月的观察期内,欧米伽-3脂肪酸-二十碳五烯酸乙酯对统一亨廷顿病分级量表的总运动评分部分(TMS)的影响。与安慰剂比较,在6个月的观察期内,乙基-EPA对舞蹈症、TMS和临床总体印象评分的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Compare with placebo the effect of ethyl-eicospaentaenoic acid an omega-3 fatty acid, on the Total Motor Score component (TMS) of the Unified Huntington's Disease Rating scale over a 6 month period of observation. Compare with placebo the effect of ethyl-EPA over a 6 month period of observation on chorea, the TMS and the clinical global impression score.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FRONTOSTRIATAL ACTIVATION IN SUBJECTS AT RISK FOR HUNTINGTON'S DISEASE
CLINICAL TRIAL: ACR16 VERSUS PLACEBO FOR THE SYMPTOMATIC TREATMENT OF HUNTINGTON
CLINICAL TRIAL: PHASE 3 STUDY OF DIMEBON IN PATIENTS WITH MILD-TO-MODERATE HUNTI
CLINICAL TRIAL: COOPERATIVE HUNTINGTON'S OBSERVATIONAL TRIAL (COHORT)
海外基金